Analysis of the incompatibility of the product with fluorescent method

The aim is to analyze the surface of the product (posterior bearing housing) with using the fluorescent method and to demonstrate the effectiveness of the sequence application like the fluorescent method and instruments of the quality management to analyze the incompatible of the product. In the production enterprise, during the fluorescent penetration test, the incompatibility was identified on the product (posterior bearing housing), i.e. the porosity cluster. The effective of the used the sequence containing the fluorescent method, the Ishikawa diagram and the 5Why method in order to identify incompatibility, and next the source cause was demonstrated. The analyze, the sequence of the methods and the proposed improvement actions can be used in other companies to analyze quality problems

Discrepancies analysis of casts of diesel engine piston

The essential material requirement for pistons concerns its parameters at different piston working temperatures at different ambient temperatures. The study employed penetrating tests in quality control of diesel engines used in passenger cars. The aim of the research was to determine the sources of casts discrepancies detected in penetrating test, using traditional quality management tools. Ultimately, the conducted analysis was aimed to reduce the number of non-compliant products or their total elimination

Discrepancies analysis of casts of diesel engine piston

The essential material requirement for pistons concerns its parameters at different piston working temperatures at different ambient temperatures. The study employed penetrating tests in quality control of diesel engines used in passenger cars. The aim of the research was to determine the sources of casts discrepancies detected in penetrating test, using traditional quality management tools. Ultimately, the conducted analysis was aimed to reduce the number of non-compliant products or their total elimination

Comprehensive improvement of the surface quality of the diesel engine piston

An important requirement for the material for pistons concerns its parameters at different temperatures of piston operation at different ambient temperatures. The study uses penetration tests in quality control of diesel engine pistons used in passenger cars. The purpose of the tests was to determine, with the use of traditional quality management tools, the sources of incompatibility of castings detected in eddy current testing. The aim of the analysis was to reduce the number of non-compliant products or to eliminate them altogether

Development of a test for recording both visual and auditory reaction times, potentially useful for future studies in patients on opioids therapy

Luca Miceli,1 Rym Bednarova,2 Alessandro Rizzardo,1 Valentina Samogin,1 Giorgio Della Rocca1 1Department of Anesthesia and Intensive Care Medicine, University of Udine, 2Department of Pain Medicine and Palliative Care, Hospital of Latisana, Latisana, Udine, Italy Objective: Italian Road Law limits driving while undergoing treatment with certain kinds of medication. Here, we report the results of a test, run as a smartphone application (app), assessing auditory and visual reflexes in a sample of 300 drivers. The scope of the test is to provide both the police force and medication-taking drivers with a tool that can evaluate the individual’s capacity to drive safely. Methods: The test is run as an app for Apple iOS and Android mobile operating systems and facilitates four different reaction times to be assessed: simple visual and auditory reaction times and complex visual and auditory reaction times. Reference deciles were created for the test results obtained from a sample of 300 Italian subjects. Results lying within the first three deciles were considered as incompatible with safe driving capabilities. Results: Performance is both age-related (r>0.5) and sex-related (female reaction times were significantly slower than those recorded for male subjects, P<0.05). Only 21% of the subjects were able to perform all four tests correctly. Conclusion: We developed and fine-tuned a test called Safedrive that measures visual and auditory reaction times through a smartphone mobile device; the scope of the test is two-fold: to provide a clinical tool for the assessment of the driving capacity of individuals taking pain relief medication; to promote the sense of social responsibility in drivers who are on medication and provide these individuals with a means of testing their own capacity to drive safely. Keywords: visual reaction time, auditory reaction time, opioids, Safedriv

Doctor@Home: Through a Telemedicine Co-production and Co-learning Journey

Telemedicine and remote visits are becoming more and more popular in several medical disciplines, including oncology. The Covid-19 pandemic has enhanced the need to continue to meet patients’ ambulatory care necessities ensuring social distancing and limiting the access to clinical facilities. The National Cancer Institute of Aviano, Italy, has recently launched a program called “Doctor @ Home” (D@H). The pillars of the program are the co-production of the oncological care and the co-learning approach, which sees the clinical staff “hand in hand” with patients to maximize the outcome of the care, trying to take advantage of the new tools offered by modern technologies

Impact of potential inappropriate NSAIDs use in chronic pain

Abstract: Pain remains one of the main reasons for medical consultation worldwide: moderate- to severe-intensity pain occurs in 19% of adult Europeans, seriously affecting the quality of their social and working lives. Nonsteroidal anti-inflammatory drugs (NSAIDs) are not recommended for long-term use and a careful surveillance to monitor for toxicity and efficacy is critical. This study aims to assess: 1) the pattern of use of NSAIDs and opioids in a population covered by a cloud-based pharmacovigilance surveillance system; and 2) potential inappropriate use. A retrospective 18-months systematic analysis on patients\u2019 pain treatment was performed. The primary endpoint was evaluating the prevalence of NSAIDs and opioids use and the duration of therapy regimen. The secondary endpoint was to investigate the prevalence of NSAIDs taken for \ue02e21 consecutive days concomitant with drugs for peptic ulcer and gastroesophageal reflux disease (GORD) or antiplatelet drugs. The yearly cost for individual users of concomitant NSAIDs for more than 21 consecutive days and of GORD medications has been estimated. A total of 3,050 subjects with chronic pain were enrolled; 97% of them took NSAIDs for \ue02e21 consecutive days; about one-fourth of these users also received drugs for peptic ulcer and GORD (Anatomical Therapeutic Chemical code A02B). The yearly cost foran individual who uses NSAIDs for \ue02e21 consecutive days as well as concomitant GORD medications is 61.23 euros. In total, 238 subjects (8%) using NSAIDs for \ue02e21 days also received one antiplatelet agent. About 11% of subjects received opioids at least once and only 2% of them carried on the therapy for more than 90 consecutive days. In evaluating the escalation in dosage as a proxy of dependence risk, this study shows no dosage escalation in our cohort of chronic pain population - that is to say we show no risk of dependence. Keywords: pain therapy, economic impact, dependenc

Cancer Rehabilitation and Physical Activity: the “Oncology in Motion” Project

Not availabl

Outpatient therapeutic chronic opioid consumption in Italy: a one-year survey.

BACKGROUND: In Italy since the 38/2010 law concerning Palliative Care and pain therapy has been promulgated, the consumption of opioids started increasing. However, despite the availability of a large amount of data regarding opioid prescription, a database including all patients on chronic opioid therapy does not yet exist. METHODS: Retrospective analysis of analgesic opioid consumption was performed between January 2013 and December 2013 using the data of national refunded medications for outpatients, collected by Italian Ministry of Health. We considered patients on chronic opioid therapy those patients with at least three opioids prescriptions in three consecutive months and/or six opioid prescriptions in six even not consecutive months in the observation period. We considered cancer patients those with neoplasm exemption code in the scheduled prescription and/or patients with at least one ROOs prescription (rapid onset opioids, approved in Italy for Break Through cancer Pain-BTcP- only). We also calculated the patient's morphine daily mean dose (MED) converting all prescribed opioids in equivalent of morphine using specific conversion tables. RESULTS: This census revealed a total of 422,542 patients in chronic therapy with opioids, of those 369.961 with chronic non-cancer pain and 52,581 with chronic cancer pain. This represents about 4% of the estimated requirement in Italy for both groups based on previous surveys regarding the prevalence of chronic pain. CONCLUSIONS: Relatively to MED, We found that in Italy chronic cancer pain patients receive doses similar to patients with cancer pain in other Literature reports, whereas patients with chronic non-cancer pain received lower dosages